ATE525470T1 - Antigene epitope des faktors viii, inhibitoren dagegen, und deren verwendungen - Google Patents
Antigene epitope des faktors viii, inhibitoren dagegen, und deren verwendungenInfo
- Publication number
- ATE525470T1 ATE525470T1 AT02732243T AT02732243T ATE525470T1 AT E525470 T1 ATE525470 T1 AT E525470T1 AT 02732243 T AT02732243 T AT 02732243T AT 02732243 T AT02732243 T AT 02732243T AT E525470 T1 ATE525470 T1 AT E525470T1
- Authority
- AT
- Austria
- Prior art keywords
- factor viii
- inhibitors against
- antigen epitopes
- fragments
- epitopes
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 229960000301 factor viii Drugs 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 239000012634 fragment Substances 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 102000014914 Carrier Proteins Human genes 0.000 abstract 1
- 108010078791 Carrier Proteins Proteins 0.000 abstract 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 102000057593 human F8 Human genes 0.000 abstract 1
- 229960000900 human factor viii Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/745—Assays involving non-enzymic blood coagulation factors
- G01N2333/755—Factors VIII, e.g. factor VIII C [AHF], factor VIII Ag [VWF]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/853,080 US20020068303A1 (en) | 1994-07-14 | 2001-05-09 | Antigenic polypeptide sequences of factor VIII, and fragments and/or epitopes of these sequences |
PCT/BE2002/000070 WO2002090542A2 (en) | 2001-05-09 | 2002-05-06 | Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE525470T1 true ATE525470T1 (de) | 2011-10-15 |
Family
ID=25314986
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02732243T ATE525470T1 (de) | 2001-05-09 | 2002-05-06 | Antigene epitope des faktors viii, inhibitoren dagegen, und deren verwendungen |
Country Status (7)
Country | Link |
---|---|
US (2) | US20020068303A1 (de) |
EP (1) | EP1399556B1 (de) |
JP (1) | JP4500494B2 (de) |
AT (1) | ATE525470T1 (de) |
CA (1) | CA2446390C (de) |
ES (1) | ES2372811T3 (de) |
WO (1) | WO2002090542A2 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0308860A (pt) * | 2002-04-18 | 2005-01-04 | Merck Patent Gmbh | Fator viii modificado |
GB0713187D0 (en) * | 2007-07-06 | 2007-08-15 | Cambridge Entpr | biomolecule binding ligands |
GB0801513D0 (en) * | 2008-01-28 | 2008-03-05 | Circassia Ltd | Peptides from factor VIII |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4649132A (en) | 1983-03-31 | 1987-03-10 | Scripps Clinic And Research Foundation | Treatment of Factor VIII inhibitors |
US4965199A (en) * | 1984-04-20 | 1990-10-23 | Genentech, Inc. | Preparation of functional human factor VIII in mammalian cells using methotrexate based selection |
KR910006424B1 (ko) | 1985-08-21 | 1991-08-24 | 인코텍스 비.브이 | 편성브리프(brief) 제조방법 |
BE1008491A3 (fr) * | 1994-07-14 | 1996-05-07 | Croix Rouge De Belgique Depart | Sequence polypeptidique antigenique du facteur viii, fragments et/ou epitopes de celle-ci. |
EP0965597A4 (de) * | 1996-12-27 | 2003-01-08 | Mochida Pharm Co Ltd | Zellmembran-wirksame medikamente |
CN1202128C (zh) * | 1998-12-08 | 2005-05-18 | 拜奥威神有限公司 | 修饰蛋白的免疫原性 |
AU2002249779A1 (en) * | 2000-12-01 | 2002-08-12 | Regents Of The University Of Minnesota | Method to treat hemophilia |
-
2001
- 2001-05-09 US US09/853,080 patent/US20020068303A1/en not_active Abandoned
-
2002
- 2002-05-06 CA CA2446390A patent/CA2446390C/en not_active Expired - Fee Related
- 2002-05-06 EP EP02732243A patent/EP1399556B1/de not_active Expired - Lifetime
- 2002-05-06 AT AT02732243T patent/ATE525470T1/de active
- 2002-05-06 JP JP2002587603A patent/JP4500494B2/ja not_active Expired - Fee Related
- 2002-05-06 ES ES02732243T patent/ES2372811T3/es not_active Expired - Lifetime
- 2002-05-06 WO PCT/BE2002/000070 patent/WO2002090542A2/en active Application Filing
-
2005
- 2005-11-03 US US11/267,631 patent/US7981865B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2446390A1 (en) | 2002-11-14 |
JP2004535393A (ja) | 2004-11-25 |
WO2002090542A8 (en) | 2004-02-12 |
EP1399556B1 (de) | 2011-09-21 |
US7981865B2 (en) | 2011-07-19 |
US20060051367A1 (en) | 2006-03-09 |
ES2372811T3 (es) | 2012-01-26 |
WO2002090542A3 (en) | 2003-12-24 |
WO2002090542A2 (en) | 2002-11-14 |
CA2446390C (en) | 2012-01-17 |
EP1399556A2 (de) | 2004-03-24 |
JP4500494B2 (ja) | 2010-07-14 |
US20020068303A1 (en) | 2002-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1118037T1 (el) | Αντισωματα εναντι του αβητα και h χρηση τους | |
WO2003045128A3 (en) | SYNTHETIC IMMUNOGENIC BUT NON-DEPOSIT-FORMING POLYPEPTIDES AND PEPTIDES HOMOLOGOUS TO AMYLOID β, PRION PROTEIN, AMYLIN, α-SYNUCLEIN, OR POLYGLUTAMINE REPEATS FOR INDUCTION OF AN IMMUNE RESPONSE THERETO | |
NO20045021L (no) | Immunologiske metoder og preparater for behandling av Alzheimers sykdom | |
DK1461073T3 (da) | Peptidagonister til prostataspecifikt antigen og anvendelser heraf | |
DE60032486D1 (de) | Prion protein peptide und deren verwendung | |
NZ503763A (en) | Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use | |
NO20031048D0 (no) | "Pseudo"-nativ kjemisk ligering | |
ATE356206T1 (de) | Menschliches krebsantigen ny eso-1/cag-3 und dazu kodierendes gen | |
ATE433491T1 (de) | Oligomerische komplexe von chimären proteinen mit verbessertem immunogenen potential | |
WO2005058937A3 (en) | A human cytotoxic t-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of muc-1 | |
IL163902A0 (en) | Antibodies against cancer antigen tmeff2 and uses thereof | |
EP1455821A4 (de) | Parathormon-antikörper und damit zusammenhängende verfahren | |
DE60228603D1 (de) | Antigene und vektoren für impfung | |
DK1370284T3 (da) | Bakteriofag-medieret immunisering | |
ATE525470T1 (de) | Antigene epitope des faktors viii, inhibitoren dagegen, und deren verwendungen | |
EP2193804A3 (de) | Rekombinantes Adenylat-Cyclase-Toxin von Bordetella induziert T-Zell-Antworten gegen tumorale Antigene | |
ATE509025T1 (de) | ßMIT MHC-KLASSE-I-PEPTIDEPITOPEN KOVALENT VERKN PFTES MEMBRANVERANKERTES BETA2-MIKROGLOBULINß | |
HUP0203251A2 (hu) | Az apolipoprotein B-100 epitópját utánzó peptidek, ezeknek megfelelő konkatemér és módosított peptidek és ezeket tartalmazó vakcinakészítmények | |
WO2003106478A3 (en) | ANTIBODIES BINDING TO ALPHAE INTEGRIN | |
BR0112141A (pt) | Peptìdeos, polipeptìdeo, composição, uso de um peptìdeo ou um polipeptìdeo, e, anticorpo | |
GB0222824D0 (en) | Bacteriophage-mediated immunisation II | |
DE60237588D1 (de) | Neue trp2-isoform mit cytotoxischen t-lymphozyten-epitopen mit hla-a2-restriktion | |
DK1399482T3 (da) | Bestemmelse af bone-sialoprotein i kropsvæsker til on-kologiske problemstillinger | |
ES2199047A1 (es) | Metodo de diagnostico inmunologico de la dirofilariosis pulmonar humana | |
MXPA04004303A (es) | Composicion farmaceutica que comprende polipeptidos del factor vii y polipeptidos pai-1. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1399556 Country of ref document: EP |